| Q34355897 | A current understanding of vascular calcification in CKD. |
| Q42726945 | Achievement of right ventricular pacing by use of a long guiding catheter in a hemodialysis patient presenting significant tortuosity of vasculature |
| Q54109862 | Activation of the mTORC1 pathway by inflammation contributes to vascular calcification in patients with end-stage renal disease. |
| Q83641432 | Aortic arch calcification evaluated on chest X-ray is a strong independent predictor of cardiovascular events in chronic hemodialysis patients |
| Q35152692 | Association of serum phosphorus variability with coronary artery calcification among hemodialysis patients |
| Q37853829 | Cell biological and physicochemical aspects of arterial calcification |
| Q61927929 | Chapter 6 Vascular Calcification Inhibitors In Relation To Cardiovascular Disease With Special Emphasis On Fetuin‐A In Chronic Kidney Disease |
| Q37722763 | Coronary artery calcification in chronic kidney disease: An update. |
| Q35530311 | Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot study |
| Q28085476 | Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity |
| Q34274681 | ENPP1 K121Q Genotype Not Associated with Coronary Artery Calcification in Korean Patients with Type 2 Diabetes Mellitus |
| Q92660912 | Effect of spironolactone on the progression of coronary calcification in peritoneal dialysis patients: a pilot study |
| Q34724266 | Effects of sodium thiosulfate on vascular calcification in end-stage renal disease: a pilot study of feasibility, safety and efficacy. |
| Q40805494 | FGF23 and inflammation |
| Q35967669 | Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients |
| Q34457107 | Fetuin-mineral complex reflects extraosseous calcification stress in CKD |
| Q46134937 | Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure |
| Q36142874 | High Serum Phosphorus Level Is Associated with Left Ventricular Diastolic Dysfunction in Peritoneal Dialysis Patients |
| Q37685693 | Hyperphosphatemia and hs-CRP Initiate the Coronary Artery Calcification in Peritoneal Dialysis Patients. |
| Q35695757 | Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients |
| Q37695914 | Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review |
| Q55265432 | Is progression of coronary artery calcification influenced by modality of renal replacement therapy? A systematic review. |
| Q37378445 | Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study. |
| Q36947028 | Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease |
| Q35059741 | Osteo-renal regulation of systemic phosphate metabolism |
| Q34640408 | Pericardial fat is associated with coronary artery calcification in non-dialysis dependent chronic kidney disease patients |
| Q36380640 | Progression of aortic arch calcification over 1 year is an independent predictor of mortality in incident peritoneal dialysis patients |
| Q45162026 | Progression of coronary calcification in pediatric chronic kidney disease stage 5. |
| Q33905277 | Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes |
| Q35013412 | Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study |
| Q34990456 | Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study |
| Q84571365 | Statins and vitamin D: a friendly association in pre-dialysis patients |
| Q37670856 | The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients. |
| Q27021447 | The role of fetuin-A in mineral trafficking and deposition |
| Q37914009 | Vascular and valvular calcification in chronic peritoneal dialysis patients |
| Q47580605 | Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients |
| Q28071582 | Vascular calcification: When should we interfere in chronic kidney disease patients and how? |